CHONGKUNDANG HOLDINGS CORP.

(주)종근당홀딩스 · KOSPI: 001630 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name: (주)종근당홀딩스
Market / ticker: KOSPI · 001630
Industry: Pharmaceuticals and medicinal chemicals
Established: 1956-01-10
Fiscal year ends: December
Website: www.ckd-holdings.com
DART corp code: 00149354
Latest revenue: ₩959.0B (FY2025)

Items worth checking

medium

Decision to issue convertible / warrant / exchangeable bonds — the filing states whether new or treasury shares back it — filed on 2 separate dates in the last 12 months, latest 2025-10-15.

Source: Material event report — Exchangeable bond issuance decision

Financial summary

KRW	FY2023	FY2024	FY2025
Revenue	₩879.8B	₩957.8B	₩959.0B
Operating income	₩17.0B	₩35.5B	₩58.3B
Net income	₩40.6B	₩40.3B	₩54.3B
Total assets	₩1.46T	₩1.50T	₩1.63T
Total liabilities	₩632.5B	₩646.0B	₩715.7B
Total equity	₩823.5B	₩849.8B	₩913.1B
Share capital	₩12.5B	₩12.5B	₩12.5B

Consolidated statements · FY2025 operating margin 6.1% · liabilities to equity 78% · Annual report FY2025 (Korean original)

Auditor opinions

Period	Auditor	Opinion
Term 71 (current)	한영회계법인	Unqualified
Term 70 (prior)	한영회계법인	Unqualified
Term 69 (two years prior)	한영회계법인	Unqualified

Largest shareholder history

No change history reported in the latest annual report.

Recent filings

Date	Filing	Original
2026-08-31	Amended: Material event report	DART
2026-08-14	Material management matter	DART
2026-08-14	Half-year report (2026.06)	DART
2026-07-27	Material management matter	DART
2026-07-01	Securities issuance results report	DART
2026-07-01	Prospectus	DART
2026-06-30	Terms finalized: Securities registration statement	DART
2026-06-30	Sustainability report (voluntary)	DART
2026-06-25	Terms finalized: Securities registration statement	DART
2026-06-25	Amended: Securities registration statement	DART
2026-06-24	Large shareholding (5%+) report	DART
2026-06-19	Securities registration statement	DART
2026-06-11	New facility investment	DART
2026-06-08	Change in shareholdings of largest shareholder	DART
2026-06-08	Large shareholding (5%+) report	DART
2026-06-01	Corporate governance report	DART
2026-05-28	Change in shareholdings of largest shareholder	DART
2026-05-28	Large shareholding (5%+) report	DART
2026-05-15	Quarterly report (2026.03)	DART
2026-05-14	Material management matter	DART

Showing the 20 most recent of 64 filings. The full brief lists all of them.

Full brief on CHONGKUNDANG HOLDINGS CORP. — $39

Every filing from the last 12 months in English, not just the 20 most recent — each linked to its Korean original
Latest half-year and quarterly figures on top of the three annual years, plus the full auditor and largest-shareholder history
Any KOSPI, KOSDAQ or KONEX company, not just the ones listed here — delivered as a private link the moment payment clears

Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Pharmaceuticals and medicinal chemicals

AHN-GOOK PHARMACEUTICAL Co., Ltd. KOSDAQ 001540
Aprogen Biologics Inc. KOSPI 003060
Aprogen, Inc KOSPI 007460
Boryung Corporation KOSPI 003850
BUKWANG PHARMACEUTICAL IND CO.,LTD KOSPI 003000
DAEWON PHARMACEUTICAL CO.,LTD KOSPI 003220

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.